Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 484

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 3
Chunk 484
---

    $– 
  
    Total assets 
    $115,019  
    $115,019  
    $–  
    $– 

    Fair Value Measurements at December 31, 2023 Using 

    Fair Value at December 31,  2023  
    Quoted Prices in Active Markets for Identical Assets  (Level 1)  
    Significant Other Observable  Inputs  (Level 2)  
    Significant Unobservable  Inputs (Level 3) 
  
    Assets: 

    Cash and cash equivalents 
    $156,178  
    $156,178  
    $–  
    $– 
  
    Total assets 
    $156,178  
    $156,178  
    $–  
    $– 

4.        Investment
in Affiliated Companies

Holocom, Inc.

In February 2007, we invested an aggregate of $370,000
in Holocom in exchange for 2,100,000 shares of Series A Preferred Stock, which represented an approximate 46% ownership interest in Holocom,
on an as-converted basis. Pursuant to the articles of incorporation of Holocom, the Series A Preferred Stock is convertible at our option
into shares of Holocom’s common stock on a one-to-one basis or is redeemable at any time after May 31, 2007 at a redemption price
equal to $0.40 per share or $840,000 in aggregate, provided Holocom has sufficient funding to redeem our shares of Series A Preferred
Stock.

     F-14 

    Mosaic ImmunoEngineering, Inc.

    Notes to Consolidated Financial Statements
    For the Years Ended December 31, 2024 and 2023 (continued)

On July 6, 2023, we entered into the Redemption Agreement
with Holocom, pursuant to which we requested full redemption of our Series A Preferred Stock. Pursuant to the Redemption Agreement, we
received cash proceeds in the amount of $336,000
upon the redemption of 840,000
shares of Series A Preferred Stock in July 2023 with the remaining shares of Series A Preferred Stock were to be redeemed over a period
of thirty (30) months beginning August 1, 2023 based on the following redemption schedule:

    Schedule of series A preferred stock to be redeemed

    Period

    Shares of Series A